Caprelsa and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Caprelsa (vandetanib), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Synthroid, and have Thyroid cancer.

The phase IV clinical study analyzes which people have Nosebleed when taking Caprelsa. It is created by eHealthMe based on reports of 1,267 people who have side effects when taking Caprelsa from the FDA, and is updated regularly.

What is Caprelsa?

Caprelsa has active ingredients of vandetanib. eHealthMe is studying from 1,268 Caprelsa users. Check the latest studies of Caprelsa.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,081 drugs and 3,091 conditions by eHealthMe. Check the latest studies of Nosebleed.

On Jul, 09, 2026

1,267 people reported to have side effects when taking Caprelsa.
Among them, 34 people (2.68%) have Nosebleed.

Among these 34 people:

How long have people been on Caprelsa when they have Nosebleed? *

What is the gender of people who have Nosebleed when taking Caprelsa? *

female: 44.12 %
male: 55.88 %

What is the age of people who have Nosebleed when taking Caprelsa? *

What are other drugs people take besides Caprelsa? *

What are other side effects people have besides Nosebleed? *

Diarrhea: 17 people, 50.00%
High Blood Pressure: 16 people, 47.06%
Rashes (redness): 11 people, 32.35%
Acne (skin problems that cause pimples): 10 people, 29.41%
Headache (pain in head): 10 people, 29.41%
Nausea (feeling of having an urge to vomit): 8 people, 23.53%
Blood Thyroid Stimulating Hormone Increased: 7 people, 20.59%
Dyspnea (difficult or laboured breathing): 6 people, 17.65%
Hypoglycemia (low blood sugar): 6 people, 17.65%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 6 people, 17.65%

What are the existing conditions these people have? *

Thyroid Cancer: 29 people, 85.29%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 20.59%
Diarrhea: 6 people, 17.65%
Blood Calcium Decreased: 6 people, 17.65%
Medullary Thyroid Cancer (type of thyroid cancer that develops in the parafollicular cells of the thyroid gland): 3 people, 8.82%
Neuroendocrine Carcinoma (cancer tumour that arise from cells of the endocrine (hormonal) and nervous systems): 1 person, 2.94%
High Blood Cholesterol: 1 person, 2.94%
Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 1 person, 2.94%
Cancer Pain: 1 person, 2.94%
Breakthrough Pain: 1 person, 2.94%

* Approximation only. Some reports may have incomplete information.

Do you take Caprelsa and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Caprelsa:

Caprelsa (1,268 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

Browse all side effects of Caprelsa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,081 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,091 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on vandetanib (the active ingredients of Caprelsa) and Caprelsa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.